Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|March 7, 2003
Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprololJari J Lilja, Janne T Backman, Jouko Laitila, et al.
British Journal of Clinical Pharmacology|July 27, 2005
Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinideMikko Niemi, Janne T Backman, Laura Juntti-Patinen, et al.
Clinical Pharmacology and Therapeutics|April 3, 2004
Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interactionMarika T Granfors, Janne T Backman, Mikko Neuvonen, et al.
Life Sciences|July 20, 2002
Expression of active human beta-glucuronidase in Sf9 cells infected with recombinant baculovirusBernhard Sperker, Thomas E Mürdter, Janne T Backman, et al.
British Journal of Clinical Pharmacology|September 18, 2004
Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinideLauri I Kajosaari, Janne T Backman, Mikko Neuvonen, et al.
Basic & Clinical Pharmacology & Toxicology|May 4, 2013
Intravenous lipid emulsion entraps amitriptyline into plasma and can lower its brain concentration--an experimental intoxication study in pigsJuho A Heinonen, Erik Litonius, Janne T Backman, et al.
Pharmacogenetics and Genomics|May 29, 2015
SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acidAleksi Tornio, Juha Vakkilainen, Mikko Neuvonen, et al.
Clinical Pharmacokinetics|July 29, 2003
Pharmacokinetic interactions with rifampicin : clinical relevanceMikko Niemi, Janne T Backman, Martin F Fromm, et al.
European Journal of Clinical Pharmacology|June 8, 2006
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamideMikko Niemi, Aleksi Tornio, Marja K Pasanen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 29, 2022
Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A in vitroMarie-Noëlle Paludetto, Mika Kurkela, Helinä Kahma, et al.
Pageof 16